MedTech News
BlurryScope: A compact, AI-powered microscope for rapid, cost-effective cancer scoring
A research team at UCLA, led by Professor Aydogan Ozcan, has introduced BlurryScope, a compact, cost-effective scanning microscope that combines simple optical hardware with advanced deep learning algorithms to assess HER2 status in breast cancer tissue samples.
WiFi signals can measure heart rate—no wearables needed
Heart rate is one of the most basic and important indicators of health, providing a snapshot into a person’s physical activity, stress and anxiety, hydration level, and more.
Widely available nasal spray reduces risk of coronavirus infection by two-thirds, clinical study suggests
A research team at Saarland University has demonstrated in a clinical study that a widely used anti-allergy nasal spray containing the active ingredient azelastine can significantly reduce the risk of infection with the SARS-CoV-2 virus. The results of the placebo-controlled trial involving 450 healthy participants have now been published in JAMA Internal Medicine.
FDA grants 510(k) clearance to 4DMedical’s CT:VQ for respiratory diagnostics
The submission for CT:VQ was supported by a clinical validation package that spanned a variety of lung conditions.
Phraxis Announces First-Ever Commercial Case of EndoForce Anastomotic Connector
The technology is compatible with all PTFE grafts and was studied extensively in the company’s pivotal clinical trial
FDA clears Imperative Care Symphony thrombectomy system for pulmonary embolism
Imperative Care announced today that the FDA granted 510(k) clearance for its Symphony thrombectomy system to treat pulmonary embolism (PE).
Medtronic gets FDA nods for MiniMed 780G with Abbott Instinct sensor, expansion to type 2
Medtronic (NYSE: MDT)+
today announced major regulatory milestones for its MiniMed 780G automated insulin delivery system.
Combination of mini-camera and AI predicts recurrent heart attack
Measurements with a miniature camera inside the coronary arteries can accurately predict whether someone will suffer a recurrent heart attack. Until now, interpreting these images was so complex that only specialized laboratories could perform it.